insights_auto
Why is ALNY down 4.96%?
Dive Deeperchevron_right
ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
$ 219.72
arrow_downward
-4.96%(-11.46) 1D
$ 219.72
0.00% (0.00)
bedtimeAfter hours
Closed: 10-р сарын 2, 16:00:01 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNY...
Open
$ 231.31
High
$ 231.36
Low
$ 219.40
Mkt. cap
29.40 тэрбум
Avg. vol.
1.55 сая
Volume
1.66 сая
P/E ratio
37.40
52-wk high
$ 495.55
52-wk low
$ 197.81
EPS
$ 5.88
Beta
0.28
Shares outstanding
133.81 сая
No. of employees
2 мян
Open
$ 231.31
High
$ 231.36
Low
$ 219.40
Mkt. cap
29.40 тэрбум
Avg. vol.
1.55 сая
Volume
1.66 сая
P/E ratio
37.40
52-wk high
$ 495.55
52-wk low
$ 197.81
EPS
$ 5.88
Beta
0.28
Shares outstanding
133.81 сая
No. of employees
2 мян
News stories
From web sources and news partners
Investing.com Canada
·
2 цагийн өмнө
Form 144 ALNYLAM PHARMACEUTICALS For: 2 October By Investing.com
Stock Titan
·
3 цагийн өмнө
An Alnylam (ALNY) officer proposes a $399K share sale that includes shares to cover an equity-award tax bill.
Simply Wall Street
·
17 цагийн өмнө
Alnylam Pharmaceuticals (ALNY) Stock Looks Above Fair Value As Shares Fell 49%
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals, Inc.